Archimedes Pharma Ltd Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Nottingham Vanuatu (1989)
Status: Acquired by Kyowa Hakko Kirin (2014)

Organization Overview

First Clinical Trial
2005
NCT00767221
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Archimedes Development Ltd | Archimedes Pharma US, Inc.